Publication|Articles|December 18, 2024
- Pharmaceutical Executive: December 2024
- Volume 44
- Issue 12
Pharmaceutical Executive: December 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive December 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 1 year ago
Trending Forwardover 1 year ago
Pharma’s ‘Best-Kept Secret’over 1 year ago
Seeking More Value, Less Costover 1 year ago
Dealmaking Dormant No Moreover 1 year ago
A Rocky Road for Regulationover 1 year ago
DTC's New Era of Engagementover 1 year ago
Holding On Tight to AI Waveover 1 year ago
The Recipe for Relief: Overcoming Industry Pain Pointsover 1 year ago
Pharma Forecasting: Key Markets Investors Can’t IgnoreNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
2
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
3
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5